| 000 | 01245 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513151623.0 | ||
| 264 | 0 | _c19981124 | |
| 008 | 199811s 0 0 eng d | ||
| 022 | _a0891-3668 | ||
| 024 | 7 |
_a10.1097/00006454-199808000-00027 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrediet, T G | |
| 245 | 0 | 0 |
_aShould we use vancomycin as prophylaxis to prevent neonatal nosocomial coagulase-negative staphylococcal septicemia? _h[electronic resource] |
| 260 |
_bThe Pediatric infectious disease journal _cAug 1998 |
||
| 300 |
_a763-4 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Letter | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xtherapeutic use |
| 650 | 0 | 4 | _aAntibiotic Prophylaxis |
| 650 | 0 | 4 |
_aCoagulase _xmetabolism |
| 650 | 0 | 4 |
_aCross Infection _xprevention & control |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aSepsis _xmicrobiology |
| 650 | 0 | 4 |
_aStaphylococcal Infections _xprevention & control |
| 650 | 0 | 4 | _aStaphylococcus aureus |
| 650 | 0 | 4 |
_aVancomycin _xtherapeutic use |
| 700 | 1 | _aFleer, A | |
| 773 | 0 |
_tThe Pediatric infectious disease journal _gvol. 17 _gno. 8 _gp. 763-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00006454-199808000-00027 _zAvailable from publisher's website |
| 999 |
_c9691559 _d9691559 |
||